Suppression of type I IFN signaling in tumors mediates resistance to anti-PD-1 treatment that can be overcome by radiotherapy

Immune checkpoint therapies exhibit impressive efficacy in some patients with melanoma or lung cancer, but the lack of response in most cases presses the question of how general efficacy can be improved. In addressing this question, we generated a preclinical tumor model to study anti-PD-1 resistanc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Res
Autors principals: Wang, Xiaohong, Schoenhals, Jonathan E, Li, Ailin, Valdecanas, David R, Ye, Huiping, Zhang, Fenglin, Tang, Chad, Krishnan, Sunil, Allison, James, Sharma, Padmanee, Hwu, Patrick, Komaki, Ritsuko, Overwijk, Willem, Gomez, Daniel R., Chang, Joe Y., Hahn, Stephen M., Cortez, Maria Angelica, Welsh, James W.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875182/
https://ncbi.nlm.nih.gov/pubmed/27821490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-15-3142
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars